Search results for "cell therapy"

When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

Crohn’s disease remains one of the most challenging inflammatory bowel diseases to manage. Patients with refractory—or treatment-resistant—Crohn’s...
Diabetes Drug Repurposed: Evogliptin Shows Promise in Preventing Disfiguring Burn Scars

Diabetes Drug Repurposed: Evogliptin Shows Promise in Preventing Disfiguring Burn Scars

Burn survivors frequently face a distressing secondary complication known as hypertrophic scarring, where the skin heals in bumpy, uneven, and raised...
Mapping Cancer’s Footprint: Specialized PET/CT Scans Pinpoint Metastasis and Recurrence

Mapping Cancer’s Footprint: Specialized PET/CT Scans Pinpoint Metastasis and Recurrence

Following a cancer diagnosis, patients and their families almost invariably ask the same urgent question: “How far has...
Why Cutting Carbs Isn’t Enough: The Critical Link Between Circadian Stability and Glycemic Success

Why Cutting Carbs Isn’t Enough: The Critical Link Between Circadian Stability and Glycemic Success

For individuals living with diabetes, dietary choices are traditionally considered the most critical factor in health...
From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

The standard of care in cancer treatment is undergoing a rapid paradigm shift. For decades, the default oncological...
Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood

Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood

Curocell, a South Korean clinical-stage biotech company specializing in chimeric antigen receptor T-cell (CAR-T)...
RNA Therapy Emerges as Critical Fast-Track for Cholesterol Control After Heart Attacks

RNA Therapy Emerges as Critical Fast-Track for Cholesterol Control After Heart Attacks

Myocardial infarction and unstable angina are life-threatening medical emergencies that occur when the blood vessels...
Nasal Drug Delivery Shows Promise for Deadly Glioblastoma Brain Tumors

Nasal Drug Delivery Shows Promise for Deadly Glioblastoma Brain Tumors

A new type of cancer treatment delivered through the nose, rather than by conventional injection, is gaining...
Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results

Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results

Celltrion has announced promising preclinical data for its investigational immuno-oncology candidate, CT-P72/ABP-102,...
Asan Medical Center Breaks Ground on Korea’s Largest Heavy-Ion Cancer Therapy Center

Asan Medical Center Breaks Ground on Korea’s Largest Heavy-Ion Cancer Therapy Center

Asan Medical Center is bringing heavy-ion therapy—one of the world's most advanced weapons against cancer—to its...
Languages

ENGLISH

English (US)

ASIAN

Монгол日本語Tiếng ViệtBahasa Indonesia中文 (简体, 中国大陆)

EUROPEAN

РусскийEspañol (España)Français (France)

MIDDLE_EAST_AFRICA

العربية